Cardiff Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.30

+0.03 (+2.36%)

As of Jun 30, 10:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +731.5% upside

Low Target $7.63

Average Target $10.81

High Target $13.89

Current Price $1.30

Current
$1.30

Target
$10.81

$7.63 $10.81 avg $13.89

Scenario Analysis

Bear Case

$7.63

486.9%

Low target

Base Case

$10.81

+731.5%

Avg target

Bull Case

$13.89

+968.5%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$4.56

-71.5% from high

52-Week Low

$1.16

+12.1% from low

Target vs 52W High

$10.81

+137.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%